| AARD |
Aardvark Therapeutics, Inc. |
11 Dec 2025 |
1 |
+$101,395 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
12 Dec 2025, 20:30 |
| AARD |
Aardvark Therapeutics, Inc. |
15 Oct 2025 |
2 |
+$5,211 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
16 Oct 2025, 18:14 |
| AARD |
Aardvark Therapeutics, Inc. |
15 Sep 2025 |
2 |
+$96,624 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
16 Sep 2025, 06:15 |
| AARD |
Aardvark Therapeutics, Inc. |
10 Sep 2025 |
3 |
+$160,654 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
12 Sep 2025, 20:28 |
| AARD |
Aardvark Therapeutics, Inc. |
28 Aug 2025 |
2 |
+$72,966 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
29 Aug 2025, 16:05 |
| AARD |
Aardvark Therapeutics, Inc. |
11 Jun 2025 |
1 |
$0 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
13 Jun 2025, 16:05 |
| AARD |
Aardvark Therapeutics, Inc. |
14 Feb 2025 |
3 |
+$264,672 |
4 |
Chief Executive Officer, Director, 10%+ Owner |
19 Feb 2025, 16:35 |
| AARD |
Aardvark Therapeutics, Inc. |
12 Feb 2025 |
0 |
$0 |
3 |
Chief Executive Officer, Director, 10%+ Owner |
12 Feb 2025, 18:49 |
| SCLX |
Scilex Holding Co |
17 Jan 2023 |
1 |
$0 |
4 |
Director |
17 Jan 2023, 16:31 |
| SCLX |
Vickers Vantage Corp. I |
10 Nov 2022 |
0 |
$0 |
3 |
Director |
15 Nov 2022, 17:27 |